NCT03898375

Brief Summary

The aim of this study is to investigate the onset, magnitude and duration of the effect of manipulating the optic flow on the gait pattern during Virtual Reality (VR)-enhanced treadmill walking compared to treadmill walking without VR in people post-stroke.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Nov 2019

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 2, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

November 25, 2019

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2019

Completed
Last Updated

April 7, 2020

Status Verified

April 1, 2020

Enrollment Period

19 days

First QC Date

March 26, 2019

Last Update Submit

April 3, 2020

Conditions

Keywords

Virtual realityoptic flowgait

Outcome Measures

Primary Outcomes (3)

  • 3D kinematic measurements

    Kinematic data of the lower limbs (i.e. movement amplitudes of the bilateral hip, knee and ankle joint) during treadmill walking will be recorder continuously.

    Kinematic data will be measured continuously for 20 minutes and will be expressed per gait cycle

  • Spatiotemporal gait parameters

    Spatiotemporal gait parameters of the lower limbs (i.e. walking speed, cadence, step length and - time, swing - and stance time, single - and double limb support period) during treadmill walking will be recorded continuously.

    Spatiotemporal gait parameters will be measured continuously for 20 minutes and will be expressed per gait cycle

  • Muscle activity (EMG)

    Muscle activity of the lower limb muscles (bilateral: M. rectus femoris, M. vastus medialis and lateralis, M. biceps femoris, M. tibialis anterior, M. gastrocnemius medialis and lateralis) will be recorded continuously during treadmill walking with the use of surface electrodes.

    Muscle activity will be measured continuously for 20 minutes and will be expressed per gait cycle

Secondary Outcomes (3)

  • Simulator Sickness Questionnaire (SSQ)

    The SSQ will be assessed twice per session (session 1 - 2 - 3 - 4): immediately before and after the participants walked for 20 minutes.

  • Physical Activity Enjoyment Scale (PACES)

    The PACES will be assessed once per session (session 1 - 2 - 3 - 4): immediately after the participants walked for 20 minutes.

  • Number of falls or stumbles

    The number of falls or stumbles will be assessed continuously for 20 minutes when patients are walking on the treadmill. The number of falls will be collected for each walking session (session 1 - 2 - 3 - 4).

Study Arms (1)

VR-enhanced treadmill walking

EXPERIMENTAL

Participants will be tested during 4 sessions of 20 minutes treadmill walking.

Other: Walking with different optic flow speeds

Interventions

Patients will perform 4 sessions of 20 minutes treadmill walking: one control session without VR and 3 walking sessions with the VR. In each VR session, patients will walk with a different optic flow speed: the same as, faster than or slower than their walking speed.

VR-enhanced treadmill walking

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosed with stroke (as defined by the World Health Organization)
  • stroke onset ≥ 6 months
  • ambulatory with an impaired gait pattern (FAC-score 2 or 3 or 4)
  • ability to walk on a treadmill for 20 minutes without bodyweight support
  • adult (≥ 18 years)
  • a body height between 155 cm and 200 cm
  • ability to signal pain, fear and discomfort
  • ability to give informed consent

You may not qualify if:

  • other neurological deficits than stroke leading to impaired gait
  • comorbidities (e.g. COPD, osteoporosis, cardiovascular instability)
  • visual and/or vestibular disorders that can interfere with the VR
  • uncontrolled spasticity significantly interfering with the movement of the lower extremities (Modified Ashworth Scale \> 2)
  • acute medical illness
  • communicative/cognitive problems leading to the inability to understand and carry out instructions
  • severe unilateral spatial neglect

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vrije Universiteit Brussel

Brussels, 1050, Belgium

Location

MeSH Terms

Conditions

Stroke

Interventions

Walking

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

LocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Officials

  • Eva Swinnen, Prof. Ph.D

    Vrije Universiteit Brussel

    PRINCIPAL INVESTIGATOR
  • Eric Kerckhofs, Prof. Ph.D

    Vrije Universiteit Brussel

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctoral Researcher

Study Record Dates

First Submitted

March 26, 2019

First Posted

April 2, 2019

Study Start

November 25, 2019

Primary Completion

December 14, 2019

Study Completion

December 14, 2019

Last Updated

April 7, 2020

Record last verified: 2020-04

Locations